image
Healthcare - Biotechnology - NASDAQ - NL
$ 17.1
-9.81 %
$ 932 M
Market Cap
-5.99
P/E
BALANCE SHEET
291 M ASSETS
-26.92%
23.6 M LIABILITIES
61.23%
268 M EQUITY
-30.28%
BALANCE SHEET DECOMPOSITION
Balance Sheet Pharvaris N.V.
image
Current Assets 289 M
Cash & Short-Term Investments 281 M
Receivables 2.94 M
Other Current Assets 5.75 M
Non-Current Assets 1.96 M
Long-Term Investments 0
PP&E 1.48 M
Other Non-Current Assets 474 K
96.35 %Total Assets$291.4m
Current Liabilities 23 M
Accounts Payable 4.56 M
Short-Term Debt 222 K
Other Current Liabilities 18.2 M
Non-Current Liabilities 639 K
Long-Term Debt 639 K
Other Non-Current Liabilities 0
19.32 %77.03 %Total Liabilities$23.6m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
ASSETS
Cash & Cash Equivalents 280.7 391.2 161.8 209.4 98.6 20.3 5.4 4.8
Short Term Investments 0 0 0 0 0 0 0 0
Receivables 2.9 1.0 0.4 0.7 0.6 0.2 0 1.06 K
Inventory 0 0 4.0 1.5 0.5 0 0 0
Other Current Assets 5.7 5.6 4.6 1.5 1.8 47.5 K 22.6 K 0
Total Current Assets 289.4 397.9 166.8 211.6 101.0 20.6 5.4 4.8
PP&E 1.5 0.5 0.6 0.4 48.5 K 12.9 K 0 0
Intangible Assets 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0
Other Long Term Assets 0 0 0 0 0 0 0 0
Other Assets 0 0 0 0 0 0 0 0
Total Assets 291.4 398.7 167.7 212.1 101.1 20.6 5.4 4.8
LIABILITIES
Accounts Payable 4.6 2.9 6.0 2.1 0.7 0.5 0.2 60.5 K
Short Term Debt 0.2 0.2 0.2 99.4 K 0 0 0 0
Other Current Liabilities 17.6 11.1 10.9 (2.5) 4.5 1.4 0.2 77.4 K
Total Current Liabilities 23.0 14.6 18.2 7.0 5.3 1.9 0.5 0.1
Long Term Debt 0.6 43.6 K 0.2 0.2 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 6.8 0 0 0 0
Total Liabilities 23.6 14.6 18.5 7.1 5.3 1.9 0.5 0.1
EQUITY
Common Stock 6.5 6.3 4.1 4.0 0.2 0.1 0.1 0.1
Retained Earnings (402.3) (265.9) (164.2) (87.6) (44.5) (18.5) (10.4) (6.1)
Other Accumulative Comprehensive Income/Loss 39.8 27.9 20.2 9.8 2.0 0.4 0.3 0.2
Total Equity 267.8 384.0 149.3 205.0 95.8 18.7 5.0 4.7
Total Liabilities and Equity 291.4 398.7 167.7 212.1 101.1 20.6 5.4 4.8
SHARES OUTSTANDING
Common Shares Outstanding 38.4 33.6 30.4 30.5 4.8 31.8